Navigation Links
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
Date:9/10/2008

Kinobeads(TM) Technology to Identify a New Generation of Drug Candidates

for Inflammatory Diseases

LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 /PRNewswire/ -- Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and market novel kinase-targeted therapeutics to treat inflammatory diseases.

The alliance gives GSK access to Cellzome's significant expertise in identifying and developing selective kinase inhibitors and its proprietary Kinobeads(TM) technology which, by screening compounds in a physiological setting, is designed to improve the predictability of these drug candidates' performance in clinical testing. Kinases are key molecular switches in cellular signaling events with a central role in many inflammatory responses and selective inhibitors offer a different approach to therapeutic intervention in diseases such as rheumatoid arthritis or multiple sclerosis.

Under the agreement GSK has exclusive options to license drug candidates from Cellzome's kinase programs directed against four identified targets, and three additional targets to be jointly identified by both parties. In the alliance, Cellzome will utilize its proprietary Kinobeads(TM) technology to discover novel small molecule inhibitors of these targets, and then will develop the most promising product candidates through to completion of a clinical proof of concept trial, unless GSK elects to exercise its option earlier. Cellzome is eligible to receive success-based milestones from GSK as product candidates are advanced. Upon Cellzome's achievement of clinical proof of concept for a product candidate for a particular kinase target, GSK would have an exclusive option to license all product candidates from that program. GSK would then assume full responsibility for further clinical development and commercialization on a worldwide basis. Ce
'/>"/>

SOURCE Cellzome Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
2. GlaxoSmithKline To Post Quarterly US Grants Report
3. GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
4. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
5. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
6. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
7. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
8. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
9. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
10. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
11. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
(Date:11/5/2009)...rstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: ...dent and CEO of Imagenetix, will be presenting the...ence on Thursday, December 3rd, at 10:30 AM PST at...CRO ,, LD MICRO is a by-invitation only newslet...nies in the micro-cap space. Since 2002, the firm ...
(Date:11/5/2009)...FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Boa...e quarter ended September 30, 2009. The Company,s ... follow. ,, Third Quarter 2009 ,, The Comp...hare for the third quarter of 2009 as compared to ...third quarter of 2008. ,, Net sales were $5.0 ...
(Date:11/5/2009)...swire-FirstCall/ -- Wound Management Technologies,... into a Letter of Intent to purchase all healthcar...nc. (OTC Bulletin Board: VHGI). The deal provides ...,000,000 shares of WNDM and a royalty agreement fo...nology being acquired from VHGI. WNDM closed at ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...of sensors or barcodes at the nanoscale, North Car...ertain types of tiny organic particles, when heate... a layer of a thin polymer film and then can rever...d time. , Selectively bringing a number of parti... it results in controllable surface patterns. Acco...
...apeutics, (Nasdaq: NKTR ) President and Chief Exe...resent at the upcoming UBS 2008 Global Life,Scienc...ork Hotel on,Tuesday, September 23, 2008 at 10:30 ... a Webcast through a link posted,on the Investor R...bsite:, http://www.nektar.com . This Webcast will ...
...gate Innocence Claims, WASHINGTON, Sept. 16 The ...ver $1.1 million to the State of Kentucky to,help ... DNA testing and,evidence may prove actual innocen...s (OJP), the funding is one of five competitive aw...hington totaling over $7.8 million., "Postconvict...
Other Biology Technology:NC State engineers discover nanoparticles can break on through 2Department of Justice Provides States With Funding for Testing in Postconviction Cases 2
(Date:11/4/2009)... Aware, Inc. (Nasdaq: AW...nd biometrics software, today reported financial r...2009. ,, Michael Tzannes, Aware,s Chairman an...e announced an agreement to sell our DSL and home ...semiconductor company being spun out of Infineon. ...
(Date:11/4/2009)...swire/ -- Global Rainmakers, Inc., an intellectual...oratory, today announced that the company has exit...commercialize its suite of technologies designed t...gs. ,, During the past four years, the company ...nd deploy a series of core--but expandable--techno...
(Date:11/3/2009)...09 -- The world,s greatest wines are the result o...nput, and something called the "terroir" -- a term...mate. , Experts will discuss terroir with an e...y, Nov. 4 in Pittsburgh. "Terroir: Winegrapes and...t the 2009 Annual Meetings of the American Society...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Great wines come from great soils 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 1Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 3Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 1Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 2Lupus Foundation of America Fosters the Next Generation of Lupus Researchers by Awarding Gina M Finzi Memorial Student Summer Fellowships to Five Stu 4531 3
... Free will and true spontaneity exist ?in fruit fl...aking study in the May 16, 2007 issue of the open-... insects are usually seen as complex robots which ...hor Björn Brembs from the Free University Berlin. ... scientists observe animals responding differently...
... A gene thought to be essential in helping chemoth...rive. In a new study of chemo patients, scientists...arian Cancer Institute found that 70 percent of su...were still alive after five years. Patients with n...e. The findings raise the possibility of a new str...
... When it comes to growing cells in a lab, techniqu... nerve cells grown in three-dimensional cultures u... grown in standard two-dimensional petri dishes. ...ue Engineering, adds to a growing body of research... affect cell growth and function. This research sh...
Other Biology News:Do fruit flies have free will? 2Gene thought to assist chemo may help cancer thrive 2Gene thought to assist chemo may help cancer thrive 3Growing nerve cells in 3-D dramatically affects gene expression 2
Bar code reader kit - for centrifuge from Thermo Scientific
CQCS kit for etra KR 4i from Thermo Scientific
...RIOMAG Magnetic Stirrers operate without any movin...ngs, making VARIOMAG Magnetic Stirrers 100% wear-f...G inductive drive can be hermetically sealed, maki...s. This is why VARIOMAG Magnetic Stirrers are part...
Fluoroskan Ascent FL, 100-240 V, one dispenser from Thermo Scientific
Biology Products: